4126-05-0

Upstream product

• 4306-64-3 1-diethylamino-6-(3,4-dimethoxyphenyl)-hex-2-yne 
• 4126-24-3 1-diethylamino-6-(3,4-dimethoxyphenyl)hexan-3-one 

Downstream Products

• 4244-03-5 2-[6-(3,4-Dimethoxy-phenyl)-3-oxo-hexyl]-2-ethyl-cyclopentane-1,3-dione 
• 1015699-20-3 C₃₃H₄₃NO₈ 
• 1015699-23-6 C₂₄H₂₆N₂O₃ 
• 1015699-17-8 ethyl 1,2,3,4-tetrahydro-6-(3-(3,4-dimethoxyphenyl)propyl)-2-benzyl-2-oxopyridine-3-carboxylate 
• 1045758-82-4 C₂₂H₂₈O₇ 
• 1015699-21-4 C₂₄H₂₆N₂O₄ 
• 1015699-18-9 C₂₆H₃₁NO₅ 

Relevant academic research and scientific papers

Synthesis of gon-4-enes

1. A therapeutic composition having progestational activity comprising as active ingredient a 17-aliphatic carboxylic acid ester of 17α-ethynyl-18-methyl-19-nortestosterone and a pharmaceutical carrier for said compound.

Synthesis of 13-alkyl-gon-4-ones

The preparation of 13-methylgon-4-enes and novel 13-polycarbonalkylgon-4-enes by a new total synthesis is described. 13-Alkylgon-4-enes having progestational, anabolic and androgenic activities are prepared by forming a tetracylic gonane structure unsaturated in the 1,3,5(10),9(11) and 14-positions, selectively reducing in the B- and C-rings, and converting the aromatic A-ring compounds so-produced to gon-4-enes by Birch reduction and hydrolysis.